Loading…
← CockpitCompetitor Analysis › 301501.SZ Hefei Hengxin Life Science and Technology Co., Ltd. Class AOpen in the cockpit ↗

Hefei Hengxin Life Science and Technology Co., Ltd. Class A301501.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Containers/Packaging
Momentum weak 25
Mkt cap
$499M
US dollars, full cap
Free float
85%
of shares outstanding
$/day
$2.62M
20-day average traded
Fwd P/E
18.5×
forward earnings
ROIC−WACC
+2.7 pp
WACC 5.8%
Hurdle
n/a
no reverse DCF
Next earnings
179 days
4 May 2027
Close · CNYCN¥23.87
1D-0.8%
1W+5.2%
1M-9.6%
3M-15.7%
6M-28.7%
YTD-45.3%
1Y-50.4%
ATR %3.3%
52w lowhigh50.9% off high

What Hefei Hengxin Life Science and Technology does

Employees: 2,586

Hefei Hengxin Life Science and Technology at a glance

Size Hefei Hengxin Life Science and Technology (301501.SZ) is a China Materials company (Containers/Packaging) with a market value of $499M, the 3871st largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥23.87 on 6 Nov 2026.

Performance Over six months the shares fell 28.7%, against -18.0% for the median peer and -16.4% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.

Growth Revenue grew 15.7% over the last twelve months (peer median +3.6%); the operating margin is 7.8% (peer median 3.4%).

Valuation It trades at 18.5× forward earnings against a peer median of 19.8× (5th cheapest of 11).

Capital Return on invested capital runs 2.7 points above its cost of capital (5.8% WACC).

Next results Next results expected around 4 May 2027 (exchange calendar; dates can move).

Relative performance

70809010011 May 202611 Aug 20266 Nov 2026Peer median 81301501.SZ 71
Six months, rebased to 100: Hefei Hengxin Life Science and Technology against the median of its 20 peers (local-currency closes).

Hefei Hengxin Life Science and Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2022FY2021
RevenueCN¥1.92BCN¥1.84BCN¥1.59BCN¥1.09BCN¥716M
Revenue growth—+16%+46%+52%—
Gross profitCN¥440MCN¥414MCN¥399Mn/aCN¥187M
EBITDAn/aCN¥360MCN¥332Mn/aCN¥133M
Net incomeCN¥129MCN¥224MCN¥220Mn/aCN¥80.3M
Free cash flow-CN¥209M-CN¥186M-CN¥78.7Mn/aCN¥9.75M
Capital expenditureCN¥436MCN¥528MCN¥453Mn/aCN¥134M
Total debtCN¥429MCN¥404MCN¥546Mn/aCN¥122M

Quarterly statements and history in the cockpit →

Hefei Hengxin Life Science and Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-10%0%688299002735BEWI688680002228000659VETN0026153015953950AGI301223UFLEX3946688683HEXCPHN301193ALGIL301501.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Hefei Hengxin Life Science and Technology is the large dot.

Fundamentals: revenue growth against valuation

-10%0%+10%25×50×75×688299002735BEWI002228VETN002615301595AGIALGIL301501.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Hefei Hengxin Life Science and Technology is the large dot.

Hefei Hengxin Life Science and Technology competitors and peer comparison

How Hefei Hengxin Life Science and Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Hefei Hengxin Life Science and Technology against its 20 peers (data as of 6 Nov 2026)
Measure301501.SZPeer medianRank in peer set
1-month return-9.6%-8.5%9th lowest of 21
6-month return-28.7%-18.0%7th lowest of 21
Distance from 52-week high-50.9%-31.9%6th lowest of 21
Revenue growth (TTM)+15.7%+3.6%3rd highest of 21
Operating margin7.8%3.4%4th highest of 21
Forward P/E18.5×19.8×5th cheapest of 11
ROIC minus cost of capital+2.7 pp-2.6 pp4th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Hefei Hengxin Life Science and Technology 301501.SZChina$499M-29%+16%8%18.5×n/an/a
Ningbo Solartron Technology 688299.SSChina$507M-34%-15%-11%20.5×16.7%+0.9%
Shenzhen Prince New Materials 002735.SZChina$514M-34%+2%-8%79.7×n/an/a
Bewi BEWI.OLNorway$483M+3%+6%4%31.3×6.7%+13.5%
Shanghai HIUV New Materials 688680.SSChina$518M-28%-34%-29%n/a25.4%-4.7%
Xiamen Hexing Packaging Printing 002228.SZChina$520M-25%+2%1%15.4×n/an/a
Zhuhai Zhongfu Enterprise 000659.SZChina$471M-39%-10%-2%n/an/an/a
Vetropack VETN.SWSwitzerland$470M-3%-5%4%23.9×0.4%+3.3%
Zhejiang Haers Vacuum Containers 002615.SZChina$466M-31%+4%3%19.1×1.9%+16.8%
Guangdong Taili Technology 301595.SZChina$536M-12%+2%3%74.4×n/an/a
Pack 3950.TJapan$550M+13%+4%7%n/a-8.4%+5.6%
HySum Flexibles Global 300501.SZChina$445M-22%+12%-2%n/a25.2%+9.1%
AGI Greenpac AGI.NSIndia$442M+2%+6%16%10.7×17.7%+16.3%
ZRP Printing 301223.SZChina$441M-23%+8%5%n/a-6.3%+7.8%
UFlex UFLEX.NSIndia$440M+29%+10%9%n/an/an/a
Tomoku 3946.TJapan$427M+17%-3%5%n/a-3.5%+5.0%
GuangDong Leary New Material Technology 688683.SSChina$586M-45%+83%5%n/an/an/a
Hexagon Composites HEX.OLNorway$423M+26%-39%-7%n/a34.2%-0.8%
CPH CPHN.SWSwitzerland$422M-1%+4%9%14.2×-5.9%-5.6%
Ningbo Homelink Eco-iTech 301193.SZChina$602M-38%+44%-4%n/an/an/a
Groupe Guillin ALGIL.PAFrance$411M-14%+4%8%7.6×-5.9%+7.4%

Questions

Which companies are Hefei Hengxin Life Science and Technology's closest peers?
The cockpit's peer set: Ningbo Solartron Technology (688299.SS), Shenzhen Prince New Materials (002735.SZ), Bewi (BEWI.OL), Shanghai HIUV New Materials (688680.SS), Xiamen Hexing Packaging Printing (002228.SZ), Zhuhai Zhongfu Enterprise (000659.SZ), Vetropack (VETN.SW), Zhejiang Haers Vacuum Containers (002615.SZ).
Is Hefei Hengxin Life Science and Technology expensive compared with its peers?
On forward p/e it trades at 18.5× against a peer median of 19.8×, 5th cheapest of 11 in its peer set.
How has Hefei Hengxin Life Science and Technology stock performed?
Over six months to 6 Nov 2026 the shares returned -28.7% against -18.0% for the median peer; over one year -50.4%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.